Orthovita applies for CE mark for Cortoss filler:

Orthovita has applied for European marketing clearance for its Cortoss Injectable bone void filler. The application includes the results of a 24-patient multicentre study of patients undergoing surgery to repair bone fractures that showed the product allowed metal screws to be used in 98% of situations in which bone screws had previously failed because of the patients' poor bone quality. Approximately 1.5 million orthopaedic procedures involving internal fixation devices that require screwing are performed worldwide each year, 10% of which fail to hold because of poor bone quality, said Malvern, Pennsylvania-based Orthovita.